Skip to content
  • Wednesday, 26 August 2026
  • 1:28 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Restoring Healthy Mitochondria Offers Potential New Pathway for Treating Chronic Nerve Pain and Addressing Underlying Causes of Neuropathy
Neuroscience & Brain Research

Restoring Healthy Mitochondria Offers Potential New Pathway for Treating Chronic Nerve Pain and Addressing Underlying Causes of Neuropathy

Rifan Muazin Jun 1, 2026 0

Chronic nerve pain, a condition that affects millions of individuals globally, often manifests as an agonizing sensitivity where even the…

Read More
Neuroscience & Brain Research

Restoring Mitochondrial Health Offers New Paradigm for Treating Chronic Nerve Pain and Diabetic Neuropathy

Rifan Muazin May 24, 2026 0

The landscape of chronic pain management is facing a potential shift as researchers at the Duke University School of Medicine…

Read More
Stanford Medicine Study Reveals Glucose as a Master Regulator of Tissue Differentiation and Cellular IdentityKing’s College London Researchers Discover Novel Aluminum Structure Capable of Replacing Precious Metals in Industrial CatalysisScience News: A Century of Empowering Public Understanding of ScienceTraumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ